Related Experiment Video
Updated: Jul 2, 2025

Use of Rabbit Eyes in Pharmacokinetic Studies of Intraocular Drugs
Published on: July 23, 2016
Chitosan and Anionic Solubility Enhancer Sulfobutylether-β-Cyclodextrin-Based Nanoparticles as Dexamethasone
Giuseppe Francesco Racaniello1, Gennaro Balenzano1, Ilaria Arduino1
1Department of Pharmacy-Pharmaceutical Sciences, University of Bari "Aldo Moro", 70125 Bari, Italy.
New mucoadhesive nanoparticles improve dexamethasone eye drop delivery for post-surgery inflammation. This innovative drug delivery system enhances corneal residence time and drug bioavailability, offering a better treatment for ocular anterior segment diseases.
Area of Science:
- Ophthalmology
- Materials Science
- Nanotechnology
Background:
- Cataract surgery is increasing, leading to ocular anterior segment (AS) inflammation.
- Current dexamethasone (DEX) eye drops require frequent administration, posing challenges.
- Improved drug delivery is needed to enhance therapeutic outcomes for AS inflammatory conditions.
Purpose of the Study:
- To develop mucoadhesive nanoparticles (NPs) for sustained ocular delivery of dexamethasone (DEX).
- To enhance DEX solubility, bioavailability, and corneal residence time.
- To create a safe and effective drug delivery system for post-cataract surgery inflammation.
Main Methods:
- Formulation of NPs using chitosan (CS) and sulfobutylether-β-cyclodextrin (SBE-β-CD) via ionotropic gelation.
- Characterization of inclusion complex formation using phase solubility, Job's plot, and transport studies.
- Evaluation of DEX-loaded NPs for residence time, release profile, permeability, and safety on animal mucosa.
Main Results:
- CS/SBE-β-CD NPs demonstrated suitable characteristics for drug loading.
- DEX-loaded NPs showed prolonged residence time on ocular mucosa.
- Enhanced drug permeability and sustained release profile were observed.
- Developed NPs exhibited no significant irritation or toxicity.
Conclusions:
- Mucoadhesive CS/SBE-β-CD NPs are an effective system for ocular drug delivery.
- The developed NPs improve DEX bioavailability and corneal penetration.
- This innovative system offers a promising alternative for treating inflammatory AS diseases.
Related Concept Videos
Drug Delivery: Miscellaneous Routes
Oral inhalation and nasal sprays swiftly transfer drugs across the respiratory epithelium's mucosal layer. Inhaled glucocorticoids and bronchodilators directly target lung conditions such as asthma, while fluticasone nasal spray mitigates allergic rhinitis.
Transdermal patches transport drugs...
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
Factors Affecting Dissolution: Particle Size and Effective Surface Area

